Severe weather cited for discontinued manufacturing

Article

PixelOptics will discontinue the atLast! Line of enhanced multifocal lenses, due to winter flood damage at the company?s primary manufacturing site in Thailand, the company announced.

Roanoke, VA-PixelOptics will discontinue the atLast! Line of enhanced multifocal lenses, due to winter flood damage at the company’s primary manufacturing site in Thailand, the company announced. The line was launched worldwide in October 2008.

“It is with deep regret that we have made the decision to discontinue production on our family of atLast! products,” said Brett Craig, PixelOptics president and CEO. “Despite significant efforts to resolve supply issues following floods at our Thailand factory, it has become apparent that production cannot be restored in a timely manner to meet current demand. This decision was not taken lightly and we remain committed to supporting our customers through this period of transition.”

The company’s emPower! Line, manufactured in Japan, is not affected. The company said its U.S. rollout for emPower! is expected to continue and would be followed by a series of European launches throughout the year.

Although the company said the loss of its atLast line is unfortunate, it provides the company the ability to focus its full effort on emPower!

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.